Overview

Study of Therapeutic Vaccination With Intensified Schedule Plus Pegasys Dual Therapy on Chronic Hepatitis B Infection

Status:
Completed
Trial end date:
2018-03-13
Target enrollment:
Participant gender:
Summary
A randomized, Open label, Single center, Prospective study to compare efficacy and safety of Therapeutic Vaccination with Intensified schedule plus Pegylated Interferon dual Therapy on Seroclearance of Hepatitis B virus Surface Antigen in Patients with Complete Virological Response Induced by Entecavir
Phase:
Phase 4
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Entecavir
Interferon-alpha
Peginterferon alfa-2a
Vaccines